Identification of oxidative post-translational modification of serum albumin in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension of sickle cell anemia.
暂无分享,去创建一个
Catherine E Costello | David H Perlman | Mark E McComb | H. Farber | C. Costello | M. Steinberg | M. McComb | E. Klings | Martin H Steinberg | Elizabeth S Klings | Hua Huang | Adam Odhiambo | Harrison W Farber | Hua Huang | Adam Odhiambo
[1] J. Grande,et al. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. , 2005, The American journal of pathology.
[2] S. Jain,et al. The effect of malonyldialdehyde on viscosity of normal and sickle red blood cells. , 1990, Biochemical medicine and metabolic biology.
[3] J. Cracowski,et al. Increased lipid peroxidation in patients with pulmonary hypertension. , 2001, American journal of respiratory and critical care medicine.
[4] H. Lehrach,et al. Sample preparation protocols for MALDI-MS of peptides and oligonucleotides using prestructured sample supports , 2003 .
[5] M. Gladwin,et al. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. , 2004, Blood.
[6] D. Carter,et al. Atomic structure and chemistry of human serum albumin , 1992, Nature.
[7] G. Allmaier,et al. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.
[8] P. Sebastiani,et al. Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma. , 2005, Physiological genomics.
[9] D. Slatter,et al. Identification of a New Cross-link and Unique Histidine Adduct from Bovine Serum Albumin Incubated with Malondialdehyde* , 2004, Journal of Biological Chemistry.
[10] M. Gladwin,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[11] G. Sahin,et al. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. , 2001, Clinical biochemistry.
[12] J. Eaton,et al. Spontaneous oxygen radical generation by sickle erythrocytes. , 1982, The Journal of clinical investigation.
[13] J. Morrow,et al. Oxidant stress but not thromboxane decreases with epoprostenol therapy. , 2005, Free radical biology & medicine.
[14] N. Voelkel,et al. Oxidative stress in severe pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.
[15] O. Jensen. Interpreting the protein language using proteomics , 2006, Nature Reviews Molecular Cell Biology.
[16] E. Klings,et al. Present and Future Treatment Strategies for Pulmonary Arterial Hypertension , 2006 .
[17] S. Jain,et al. The accumulation of malonyldialdehyde, an end product of membrane lipid peroxidation, can cause potassium leak in normal and sickle red blood cells. , 1989, Biochemical medicine and metabolic biology.
[18] R. Hebbel,et al. Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia. , 1984, Blood.
[19] F. Boakye-Agyeman,et al. Oxidative Stress and Vaso-Occlusion in Sickle Cell Disease: Role of Activated Leukocytes and Redox Active Iron. , 2005 .
[20] E. Shacter. QUANTIFICATION AND SIGNIFICANCE OF PROTEIN OXIDATION IN BIOLOGICAL SAMPLES* , 2000, Drug metabolism reviews.
[21] G. Kato,et al. Sickle cell disease and nitric oxide: a paradigm shift? , 2006, The international journal of biochemistry & cell biology.
[22] P. Nurden,et al. Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome. , 2004, Blood.
[23] P. Ghezzi,et al. Redox proteomics: Identification of oxidatively modified proteins , 2003, Proteomics.
[24] A. Prasad,et al. Altered amount and activity of superoxide dismutase in sickle cell anemia , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] M. Steinberg. Pathophysiologically based drug treatment of sickle cell disease. , 2006, Trends in pharmacological sciences.
[26] G. Aldini,et al. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal. , 2006, Journal of mass spectrometry : JMS.
[27] S. Jain,et al. A novel phospholipid in irreversibly sickled cells: evidence for in vivo peroxidative membrane damage in sickle cell disease. , 1984, Blood.
[28] M. Karas,et al. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.
[29] M. Filip,et al. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. , 1990, The Journal of clinical investigation.
[30] A. Carrascosa,et al. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. , 2003, Free radical biology & medicine.
[31] E. Wayner,et al. Circulating activated endothelial cells in sickle cell anemia. , 1997, The New England journal of medicine.
[32] S. Menini,et al. Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[33] Bruce Barton,et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. , 2006, JAMA.
[34] A. Blann,et al. Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis , 2002, American journal of hematology.
[35] R. Osarogiagbon,et al. The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy , 2004, Microcirculation.
[36] R. Hebbel,et al. Amendment history : Erratum ( September 2000 ) Hypoxia / reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice , 2018 .
[37] T. Montine,et al. Lipid peroxidation in human proteinuric disease. , 2001, Kidney international.
[38] S. Barnes,et al. Modification of Cytochrome c by 4-hydroxy- 2-nonenal: Evidence for histidine, lysine, and arginine-aldehyde adducts , 2004, Journal of the American Society for Mass Spectrometry.
[39] E. Fibach,et al. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants , 2006, British journal of haematology.
[40] H. Farber,et al. Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress. , 2001, American journal of respiratory and critical care medicine.
[41] H. Chung,et al. Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[42] R. Hanada,et al. Improved Outcome of Combination Therapy with ATRA, Anthracyclines and Cytarabine, AML99-M3 Protocol, for Childhood Acute Promyelocytic Leukemia. , 2005 .
[43] A. Scaloni,et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. , 2005, Mass spectrometry reviews.
[44] Domenico Fedele,et al. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update. , 2006, Mass spectrometry reviews.